Physician profile
Jay M Rubin
NPI 1851386353
$942.85
in general payments reported to CMS, 2019-2025
11 companies · $80.40 in 2025
The $80.40 reported for 2025 was less than what a typical Ophthalmology provider received nationally (typical 2025 total: $384).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $357 · 2021: $97.06 · 2022: $173 · 2023: $68.91 · 2024: $166 · 2025: $80.40.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $298 · Education: $17.84.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $297.82 |
| Education | $17.84 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Bausch & Lomb, A Division of Bausch Health US, LLC | $248.12 | 2019 | |
| Abbvie INC. | $208.03 | 2022-2025 | Lumigan, Alphagan P |
| Harrow Eye, LLC | $124.99 | 2024 | Vevye |
| Alcon Vision LLC | $112.97 | 2022 | |
| Novartis Pharmaceuticals Corporation | $108.93 | 2019 | |
| Carl Zeiss Meditec, INC. | $57.26 | 2021 | |
| Bausch & Lomb Americas INC. | $42.75 | 2023 | Miebo |
| Allergan, INC. | $39.80 | 2021 |
3 companies reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jay Rubin listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.